How A Drug Co.'s Misreporting Earned A Whistleblower $40M
A whistleblower receiving a more than $40 million cut of the recent $233.7 million settlement between the U.S. Department of Justice and drugmaker Mallinckrodt had flagged his concerns internally, but resigned...To view the full article, register now.
Already a subscriber? Click here to view full article